In a survey, respondents use benefit enhancement strategies that correlate with positive 5-MeO-DMT experiences. This may open the way for further research and emphasis on harm reduction.
Read moreForbes on 5-MeO-DMT
Forbes has an article on the psychoactive toad, risks and conservation issues.
Read moreResearch on 5-MeO-DMT
In addition to reducing symptoms of depression, the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) appears to cause changes in inflammatory biomarkers.
Read moreBufu Alvarius, 5-MeO-DMT
This article looks at the risks and potential benefits of the psychedeic toad, Bufo alvarius.
Read more5-MeO-DMT
New research looks at the potential benefits and risks of 5-MeO-DMT.
Read more